Accuracy and Patient Acceptability of Flash Glucose Monitoring in Women with Diabetes in Pregnancy

Date Added
January 18th, 2022
PRO Number
Pro00117649
Researcher
Matthew Finneran

List of Studies


Keywords
Obstetrics and Gynecology
Summary

This study will access the accuracy of the FreeStyle Libre system when compared to a finger stick blood glucose test. We will also look at a patients satisfaction with the Freestyle Libre system.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

A Randomized Controlled Trial of Women Involved in Supporting Health (WISH), a Peer-Led Intervention to Improve Postpartum Retention in HIV Care

Date Added
April 18th, 2022
PRO Number
Pro00118631
Researcher
Gweneth Lazenby

List of Studies


Keywords
Obstetrics and Gynecology
Summary

The purpose of the study is to learn more about programs that can improve the health and wellbeing of mothers and their babies during the period after delivery. Women living with HIV experience diverse health problems in the period directly after delivery.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

Glycemic Profile in At Risk Women Without Diabetes and Macrosomic Fetuses

Date Added
July 19th, 2022
PRO Number
Pro00121993
Researcher
Matthew Finneran

List of Studies


Keywords
Obstetrics and Gynecology
Summary

This study is to collect data to assess the benefit of 3rd trimester glucose surveillance in non-diabetic women with big babies.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age with Moderate to Severe Endometriosis-related Pain

Date Added
July 5th, 2023
PRO Number
Pro00129682
Researcher
David Soper

List of Studies


Keywords
Obstetrics and Gynecology
Summary

The purpose of this global study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 (50, 100, and 150 mg twice a day [BID]) in pre-menopausal women between 18 and 49 years of age (inclusive), who have moderate to severe endometriosis-related pain.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu

The efficacy and safety of a CCT-102 regimen versus expectant management in the treatment of first trimester pregnancy loss

Date Added
January 23rd, 2024
PRO Number
Pro00133752
Researcher
Angela Dempsey-Fanning

List of Studies


Keywords
Obstetrics and Gynecology
Summary

The purpose of this study is to determine the efficacy and safety of a treatment regimen on women who have been diagnosed with a first trimester pregnancy loss. Women enrolled will be randomized to taking medication or expectant management.

Institution
MUSC
Recruitment Contact
Jesslyn Payne
843-792-7525
paynej@musc.edu



-- OR --